[How would the development of substitution treatments modify the care of drug addicts?].
Charles-Nicolas
A
A
CHU de Fort-de-France.
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D004198:Disease Susceptibility; D011307:Drug Prescriptions; D005194:Family Practice; D005602:France; D006801:Humans; D007880:Legislation, Drug; D008691:Methadone / Q000627:therapeutic use*; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012307:Risk Factors; D019966:Substance-Related Disorders / Q000534:rehabilitation* / Q000628:therapy
D011619:Psychotropic Drugs; D008691:Methadone
Comment le développement des traitements de substitution modifierait-il la prise en charge des toxicomanes?